Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin.

about

Staphylococcus aureus inactivates daptomycin by releasing membrane phospholipids.Successful management of methicillin-resistant Staphylococcus aureus bacteremia complicated with diffuse myelitis.Daptomycin.

P2860

Q38404983-3C182B78-7A8A-4E50-82B6-FCE4AC9A2139 Q44250798-D9FFEBA9-7479-4954-BC32-F7762C20236E Q47616115-1B343725-804D-45E8-9952-B0827DC54683

P2860

Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin.

Item

http://www.wikidata.org/entity/Q36401160

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Daptomycin-Nonsusceptible Stap ...... ith Daptomycin and Gentamicin.

@ast

Daptomycin-Nonsusceptible Stap ...... ith Daptomycin and Gentamicin.

@en

type

Item

label

Daptomycin-Nonsusceptible Stap ...... ith Daptomycin and Gentamicin.

@ast

Daptomycin-Nonsusceptible Stap ...... ith Daptomycin and Gentamicin.

@en

prefLabel

Daptomycin-Nonsusceptible Stap ...... ith Daptomycin and Gentamicin.

@ast

Daptomycin-Nonsusceptible Stap ...... ith Daptomycin and Gentamicin.

@en

P1476

Daptomycin-Nonsusceptible Stap ...... with Daptomycin and Gentamicin

@en

P2093

Anton Y Peleg

http://www.w3.org/2001/XMLSchema#string

Jhih-Hang Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR

Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus

The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion.

Penetration of daptomycin into bone and synovial fluid in joint replacement.

Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.

In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model

Transposon library screening for identification of genetic loci participating in intrinsic susceptibility and acquired resistance to antistaphylococcal agents.

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.

Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects.

P304

1256-1267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/GENES6041256

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anton Y. Peleg

Jhih-Hang Jiang

P577

2015-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

285386143

http://www.w3.org/2001/XMLSchema#string

P698

26633517

http://www.w3.org/2001/XMLSchema#string

P921

gentamicin

P932

4690039

http://www.w3.org/2001/XMLSchema#string

Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin.

about

P2860

P2860

Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932